JP2022520672A5 - - Google Patents
Info
- Publication number
- JP2022520672A5 JP2022520672A5 JP2021569259A JP2021569259A JP2022520672A5 JP 2022520672 A5 JP2022520672 A5 JP 2022520672A5 JP 2021569259 A JP2021569259 A JP 2021569259A JP 2021569259 A JP2021569259 A JP 2021569259A JP 2022520672 A5 JP2022520672 A5 JP 2022520672A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- occupied
- variable region
- amino acid
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024209068A JP7843068B2 (ja) | 2019-02-08 | 2024-11-29 | タウを認識する抗体 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803334P | 2019-02-08 | 2019-02-08 | |
| US62/803,334 | 2019-02-08 | ||
| US201962813124P | 2019-03-03 | 2019-03-03 | |
| US62/813,124 | 2019-03-03 | ||
| US201962855434P | 2019-05-31 | 2019-05-31 | |
| US62/855,434 | 2019-05-31 | ||
| PCT/US2020/017357 WO2020163817A1 (en) | 2019-02-08 | 2020-02-07 | Antibodies recognizing tau |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024209068A Division JP7843068B2 (ja) | 2019-02-08 | 2024-11-29 | タウを認識する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520672A JP2022520672A (ja) | 2022-03-31 |
| JP2022520672A5 true JP2022520672A5 (enExample) | 2023-02-15 |
| JP7681316B2 JP7681316B2 (ja) | 2025-05-22 |
Family
ID=71947192
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569259A Active JP7681316B2 (ja) | 2019-02-08 | 2020-02-07 | タウを認識する抗体 |
| JP2024209068A Active JP7843068B2 (ja) | 2019-02-08 | 2024-11-29 | タウを認識する抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024209068A Active JP7843068B2 (ja) | 2019-02-08 | 2024-11-29 | タウを認識する抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220275067A1 (enExample) |
| EP (1) | EP3921343A4 (enExample) |
| JP (2) | JP7681316B2 (enExample) |
| KR (1) | KR20210125037A (enExample) |
| CN (2) | CN113597431B (enExample) |
| AU (1) | AU2020219374B2 (enExample) |
| BR (1) | BR112021015501A2 (enExample) |
| CA (1) | CA3128392A1 (enExample) |
| CO (1) | CO2021011140A2 (enExample) |
| IL (1) | IL285444A (enExample) |
| MX (1) | MX2021009440A (enExample) |
| PE (1) | PE20211709A1 (enExample) |
| SG (1) | SG11202106717PA (enExample) |
| WO (1) | WO2020163817A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014165271A2 (en) | 2013-03-13 | 2014-10-09 | Neotope Biosciences Limited | Tau immunotherapy |
| US10906964B2 (en) | 2016-05-02 | 2021-02-02 | Prothena Biosciences Limited | Antibodies recognizing tau |
| EP3452507B1 (en) | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau immunotherapy |
| MX2018013384A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| SG11201910066QA (en) | 2017-05-02 | 2019-11-28 | Prothena Biosciences Ltd | Antibodies recognizing tau |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| SG11202106717PA (en) * | 2019-02-08 | 2021-07-29 | Prothena Biosciences Ltd | Antibodies recognizing tau |
| TWI859197B (zh) | 2019-03-03 | 2024-10-21 | 愛爾蘭商普羅帝納生物科學公司 | 識別ｔａｕ之抗體 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| CA3226301A1 (en) * | 2021-07-09 | 2023-01-12 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| IL316143A (en) | 2022-04-15 | 2024-12-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy |
| CN117003872A (zh) * | 2022-04-28 | 2023-11-07 | 北京天广实生物技术股份有限公司 | 含有突变轻链可变区骨架的单链抗体片段 |
| JP2023175325A (ja) * | 2022-05-30 | 2023-12-12 | 学校法人順天堂 | タウオパチーの鑑別診断法 |
| WO2025198916A1 (en) * | 2024-03-16 | 2025-09-25 | Abbvie Inc. | Anti-tau antibodies |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001018546A2 (en) * | 1999-09-09 | 2001-03-15 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening for inhibitors of 'paired helical filaments' |
| US8754034B2 (en) * | 2009-02-06 | 2014-06-17 | The Regents Of The University Of California | Structure-based design of peptide inhibitors of amyloid fibrillation |
| CN102596236B (zh) * | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| WO2012106363A2 (en) * | 2011-01-31 | 2012-08-09 | Intellect Neurosciences Inc. | Treatment of tauopathies |
| GB201111361D0 (en) | 2011-07-04 | 2011-08-17 | Nordic Bioscience As | Biochemical markers for neurodegenerative conditions |
| EP3275461A1 (en) | 2011-09-19 | 2018-01-31 | Axon Neuroscience SE | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field |
| WO2013059786A1 (en) * | 2011-10-21 | 2013-04-25 | The Ohio State University | Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease |
| US9200068B2 (en) * | 2012-12-18 | 2015-12-01 | Regents Of The University Of Minnesota | Compositions and methods related to tauopathy |
| WO2014165271A2 (en) * | 2013-03-13 | 2014-10-09 | Neotope Biosciences Limited | Tau immunotherapy |
| US20150253341A1 (en) * | 2014-02-10 | 2015-09-10 | Merck Sharp & Dohme Corp. | Quantification of tau in biological samples by immunoaffinity enrichment and mass spectrometry |
| NZ775762A (en) * | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| JP7725185B2 (ja) * | 2015-10-06 | 2025-08-19 | アレクトル エルエルシー | 抗ｔｒｅｍ２抗体及びその使用方法 |
| US11319372B2 (en) * | 2017-02-21 | 2022-05-03 | Remd Biotherapeutics, Inc. | Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4) |
| SG11202106717PA (en) * | 2019-02-08 | 2021-07-29 | Prothena Biosciences Ltd | Antibodies recognizing tau |
-
2020
- 2020-02-07 SG SG11202106717PA patent/SG11202106717PA/en unknown
- 2020-02-07 EP EP20753068.4A patent/EP3921343A4/en active Pending
- 2020-02-07 AU AU2020219374A patent/AU2020219374B2/en active Active
- 2020-02-07 PE PE2021001286A patent/PE20211709A1/es unknown
- 2020-02-07 JP JP2021569259A patent/JP7681316B2/ja active Active
- 2020-02-07 WO PCT/US2020/017357 patent/WO2020163817A1/en not_active Ceased
- 2020-02-07 BR BR112021015501-5A patent/BR112021015501A2/pt unknown
- 2020-02-07 CA CA3128392A patent/CA3128392A1/en active Pending
- 2020-02-07 KR KR1020217028112A patent/KR20210125037A/ko active Pending
- 2020-02-07 MX MX2021009440A patent/MX2021009440A/es unknown
- 2020-02-07 US US17/429,288 patent/US20220275067A1/en active Pending
- 2020-02-07 CN CN202080018281.7A patent/CN113597431B/zh active Active
- 2020-02-07 CN CN202510128272.8A patent/CN119954947A/zh active Pending
-
2021
- 2021-08-08 IL IL285444A patent/IL285444A/en unknown
- 2021-08-24 CO CONC2021/0011140A patent/CO2021011140A2/es unknown
-
2024
- 2024-11-29 JP JP2024209068A patent/JP7843068B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025029046A5 (enExample) | ||
| JP2022506719A5 (enExample) | ||
| IL262726B1 (en) | Antibodies recognizing tau | |
| JP2019525724A5 (enExample) | ||
| JP2019122405A5 (enExample) | ||
| JP2020536532A5 (enExample) | ||
| JP2022524588A5 (enExample) | ||
| JP2023134618A5 (enExample) | ||
| JP2018509889A5 (enExample) | ||
| JP2018506277A5 (enExample) | ||
| JP2018510617A5 (enExample) | ||
| JP2020528768A5 (enExample) | ||
| JP2022520868A5 (enExample) | ||
| JP2020513791A5 (enExample) | ||
| JP2019525728A5 (enExample) | ||
| JP2024520188A5 (enExample) | ||
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| JP2016539176A5 (enExample) | ||
| JP2012530496A5 (enExample) | ||
| JP2022520672A (ja) | タウを認識する抗体 | |
| JP6633520B2 (ja) | プロアポトーシス活性を有するヒトｉｇｇ１由来抗体 | |
| JP2024501539A5 (enExample) | ||
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2020520231A5 (enExample) | ||
| JP2016503067A5 (enExample) |